Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

127.00p
   
  • Change Today:
    -1.50p
  • 52 Week High: 139.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 89,452
  • Market Cap: £133.06m
  • RiskGrade: 118

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
22.71% above the market average22.71% above the market average22.71% above the market average22.71% above the market average22.71% above the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average
1yr Revenue Growth
55.64% below the market average55.64% below the market average55.64% below the market average55.64% below the market average55.64% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
15.8% below the market average15.8% below the market average15.8% below the market average15.8% below the market average15.8% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
1yr DPS Growth
3.68% above the market average3.68% above the market average3.68% above the market average3.68% above the market average3.68% above the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
55.52% below the market average55.52% below the market average55.52% below the market average55.52% below the market average55.52% below the market average
84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average
Price Book Ratio
26.03% below the market average26.03% below the market average26.03% below the market average26.03% below the market average26.03% below the market average
35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
57.35% above the market average57.35% above the market average57.35% above the market average57.35% above the market average57.35% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Price Chg 3m
16.83% below the market average16.83% below the market average16.83% below the market average16.83% below the market average16.83% below the market average
5% below the sector average5% below the sector average5% below the sector average5% below the sector average5% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
73.72% above the market average73.72% above the market average73.72% above the market average73.72% above the market average73.72% above the market average
58.97% above the sector average58.97% above the sector average58.97% above the sector average58.97% above the sector average58.97% above the sector average
Momentum 20
67.87% above the market average67.87% above the market average67.87% above the market average67.87% above the market average67.87% above the market average
58.97% above the sector average58.97% above the sector average58.97% above the sector average58.97% above the sector average58.97% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
16.77% below the market average16.77% below the market average16.77% below the market average16.77% below the market average16.77% below the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average
ROCE
73.31% above the market average73.31% above the market average73.31% above the market average73.31% above the market average73.31% above the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
21.14% above the market average21.14% above the market average21.14% above the market average21.14% above the market average21.14% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average
Forecast EPS
43.55% below the market average43.55% below the market average43.55% below the market average43.55% below the market average43.55% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
43.54% above the market average43.54% above the market average43.54% above the market average43.54% above the market average43.54% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Operating Profit Loss
24.42% above the market average24.42% above the market average24.42% above the market average24.42% above the market average24.42% above the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
30.00% above the market average30.00% above the market average30.00% above the market average30.00% above the market average30.00% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average
Cash
6.01% above the market average6.01% above the market average6.01% above the market average6.01% above the market average6.01% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
13.73% above the market average13.73% above the market average13.73% above the market average13.73% above the market average13.73% above the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Buys 1y
27.04% above the market average27.04% above the market average27.04% above the market average27.04% above the market average27.04% above the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
27.91% above the market average27.91% above the market average27.91% above the market average27.91% above the market average27.91% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 127.00p
Change Today -1.50p
% Change -1.17 %
52 Week High 139.50
52 Week Low 96.00
Volume 89,452
Shares Issued 104.77m
Market Cap £133.06m
RiskGrade 118

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
76.95% below the market average76.95% below the market average76.95% below the market average76.95% below the market average76.95% below the market average
35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average35.29% above the sector average
Price Trend
56.60% above the market average56.60% above the market average56.60% above the market average56.60% above the market average56.60% above the market average
69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average
Income
1.07% below the market average1.07% below the market average1.07% below the market average1.07% below the market average1.07% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
31.9% below the market average31.9% below the market average31.9% below the market average31.9% below the market average31.9% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Final Interim
Ex-Div 25-Apr-19 04-Oct-18
Paid 24-May-19 02-Nov-18
Amount 2.75p 1.10p

Trades for 21-Aug-2019

Time Volume / Share Price
16:09 1,000 @ 128.50p
14:43 31,130 @ 128.00p
14:41 787 @ 128.00p
13:06 150 @ 128.00p
11:54 3,040 @ 128.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page